Published in Neurology on January 11, 2000
Neurofibromatosis type 2 (NF2): a clinical and molecular review. Orphanet J Rare Dis (2009) 2.00
Update from the 2011 International Schwannomatosis Workshop: From genetics to diagnostic criteria. Am J Med Genet A (2013) 1.72
Predictors of the risk of mortality in neurofibromatosis 2. Am J Hum Genet (2002) 1.37
Magnetic resonance findings of neurofibromatosis type 2: a case report. Cases J (2009) 1.27
Clinical features of schwannomatosis: a retrospective analysis of 87 patients. Oncologist (2012) 1.27
Consensus recommendations to accelerate clinical trials for neurofibromatosis type 2. Clin Cancer Res (2009) 1.25
Neurofibromatosis type 2. J Med Genet (2000) 1.22
Loss-of-function mutations in SMARCE1 cause an inherited disorder of multiple spinal meningiomas. Nat Genet (2013) 1.05
Genomic profiling distinguishes familial multiple and sporadic multiple meningiomas. BMC Med Genomics (2009) 1.03
Genetic predisposition to peripheral nerve neoplasia: diagnostic criteria and pathogenesis of neurofibromatoses, Carney complex, and related syndromes. Acta Neuropathol (2011) 0.95
Multiple meningiomas: differential involvement of the NF2 gene in children and adults. J Med Genet (2005) 0.93
Intracerebral Meningiomas. Curr Treat Options Neurol (2004) 0.93
Incidence and mortality of neurofibromatosis: a total population study in Finland. J Invest Dermatol (2014) 0.91
The importance of nerve microenvironment for schwannoma development. Acta Neuropathol (2016) 0.89
Emotional functioning of patients with neurofibromatosis tumor suppressor syndrome. Genet Med (2012) 0.87
Ophthalmological manifestations in segmental neurofibromatosis type 1. Br J Ophthalmol (2004) 0.85
Varied presentation of schwannoma - a case study. Case Rep Oncol (2010) 0.85
News on the genetics, epidemiology, medical care and translational research of Schwannomas. J Neurol (2006) 0.84
Evaluation of NF2 gene deletion in sporadic schwannomas, meningiomas, and ependymomas by chromogenic in situ hybridization. Hum Pathol (2007) 0.81
Localized tongue Amyloidosis in a Patient with Neurofibromatosis type II. Head Neck Pathol (2011) 0.80
Childhood neurofibromatosis type 2 (NF2) and related disorders: from bench to bedside and biologically targeted therapies. Acta Otorhinolaryngol Ital (2016) 0.79
The question of familial meningiomas and schwannomas: NF2B or not to be? Neurology (2000) 0.79
Regression of schwannomas induced by adeno-associated virus-mediated delivery of caspase-1. Hum Gene Ther (2013) 0.78
Update from the 2013 International Neurofibromatosis Conference. Am J Med Genet A (2014) 0.78
Microcystic/Reticular Schwannoma Arising in the Submandibular Gland: A Rare Benign Entity that Mimics More Common Salivary Gland Carcinomas. Head Neck Pathol (2015) 0.77
Age associated increase in the prevalence of chromosome 22q loss of heterozygosity in histological subsets of benign meningioma. J Med Genet (2005) 0.76
Brain-sparing total meningeal radiation for a patient with widespread progressive meningiomas using helical intensity modulated radiation. Clin Neurol Neurosurg (2008) 0.75
A rare case of concurrent penile and spinal schwannomas. Urol Ann (2016) 0.75
The molecular pathogenesis of schwannomatosis, a paradigm for the co-involvement of multiple tumour suppressor genes in tumorigenesis. Hum Genet (2016) 0.75
Frequency of loss of heterozygosity of the NF2 gene in schwannomas from Croatian patients. Croat Med J (2012) 0.75
[Hereditary tumor syndromes in neuropathology]. Pathologe (2017) 0.75
Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med (2000) 25.49
Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer (1999) 6.73
Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med (2001) 6.33
Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet (2001) 6.23
Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma. JAMA (2001) 5.99
Data quality and quality control of a population-based cancer registry. Experience in Finland. Acta Oncol (1994) 4.89
Inherited susceptibility to uterine leiomyomas and renal cell cancer. Proc Natl Acad Sci U S A (2001) 3.31
Estimates of cancer incidence and mortality in Europe in 1995. Eur J Cancer (2002) 3.17
Coeliac disease--associated disorders and survival. Gut (1994) 3.13
Aggressiveness of screen-detected breast cancers. Lancet (1995) 3.07
Risk of second malignant neoplasms among long-term survivors of testicular cancer. J Natl Cancer Inst (1997) 2.83
Adverse long-term effects of brain radiotherapy in adult low-grade glioma patients. Neurology (2001) 2.72
Survival of cancer patients in Finland 1955-1994. Acta Oncol (1999) 2.67
Cancer in patients with ataxia-telangiectasia and in their relatives in the nordic countries. J Natl Cancer Inst (2001) 2.59
Decreasing late mortality among five-year survivors of cancer in childhood and adolescence: a population-based study in the Nordic countries. J Clin Oncol (2001) 2.48
Effectiveness of the public health policy for breast cancer screening in Finland: population based cohort study. BMJ (1997) 2.41
Social class as a prognostic factor in breast cancer survival. Cancer (1990) 2.37
Risk of cancer in Finnish children living close to power lines. BMJ (1993) 2.29
Incidence of cancer among persons with schizophrenia and their relatives. Arch Gen Psychiatry (2001) 2.23
Breast cancer incidence and mortality trends in 16 European countries. Eur J Cancer (2003) 2.14
Second cancers among long-term survivors of Hodgkin's disease diagnosed in childhood and adolescence. J Clin Oncol (2000) 2.09
From cross-tabulations to multipurpose exposure information systems: a new job-exposure matrix. Am J Ind Med (1998) 2.07
Does anyone survive pancreatic ductal adenocarcinoma? A nationwide study re-evaluating the data of the Finnish Cancer Registry. Gut (2005) 2.07
Hopelessness and risk of mortality and incidence of myocardial infarction and cancer. Psychosom Med (1997) 2.06
ICAM-2 redistributed by ezrin as a target for killer cells. Nature (1996) 2.04
Progression of asbestosis predicts lung cancer. Chest (1998) 2.02
Association of ezrin with intercellular adhesion molecule-1 and -2 (ICAM-1 and ICAM-2). Regulation by phosphatidylinositol 4, 5-bisphosphate. J Biol Chem (1998) 2.01
Recent adverse trends in semen quality and testis cancer incidence among Finnish men. Int J Androl (2011) 1.96
Indoor radon exposure and risk of lung cancer: a nested case-control study in Finland. J Natl Cancer Inst (1996) 1.93
Multiple cancer--an epidemiologic exercise in Finland. J Natl Cancer Inst (1985) 1.87
Work-related cancer in the Nordic countries. Scand J Work Environ Health (1999) 1.84
Arsenic concentrations in well water and risk of bladder and kidney cancer in Finland. Environ Health Perspect (1999) 1.84
Basal cell skin carcinoma and other nonmelanoma skin cancers in Finland from 1956 through 1995. Arch Dermatol (1999) 1.84
Elevated cancer incidence in patients with dermatomyositis: a population based study. J Rheumatol (1995) 1.84
Atypical and anaplastic meningiomas: radiology, surgery, radiotherapy, and outcome. Surg Neurol (1986) 1.83
Excess mortality related to alcohol and smoking among hospital-treated patients with psoriasis. Arch Dermatol (1999) 1.83
High resolution deletion analysis of constitutional DNA from neurofibromatosis type 2 (NF2) patients using microarray-CGH. Hum Mol Genet (2001) 1.79
Gynaecological infections as risk determinants of subsequent cervical neoplasia. Acta Oncol (2000) 1.71
Chlamydia trachomatis seroprevalence atlas of Finland 1983-2003. Sex Transm Infect (2007) 1.69
Polarization of NK cell cytoskeleton upon conjugation with sensitive target cells. J Immunol (1983) 1.67
Malignancies in cases with screening-identified evidence of coeliac disease: a long-term population-based cohort study. Gut (2008) 1.64
Risk of leukemia after platinum-based chemotherapy for ovarian cancer. N Engl J Med (1999) 1.63
Mechanisms for regulating expression of membrane isoforms of Fc gamma RIII (CD16). Science (1989) 1.63
Increased risk of cancer in patients with fumarate hydratase germline mutation. J Med Genet (2005) 1.61
Expression of endothelial cell-specific receptor tyrosine kinases and growth factors in human brain tumors. Am J Pathol (1995) 1.60
Trends in cancer incidence in the Nordic countries. A collaborative study of the five Nordic Cancer Registries. Acta Pathol Microbiol Immunol Scand Suppl (1986) 1.60
Familial breast cancer in southern Finland: how prevalent are breast cancer families and can we trust the family history reported by patients? Eur J Cancer (2000) 1.59
Chlamydia trachomatis infection as a risk factor for invasive cervical cancer. Int J Cancer (2000) 1.58
Cancer incidence among 78,000 asthmatic patients. Int J Epidemiol (1993) 1.58
Elevated lung cancer risk among persons with depressed mood. Am J Epidemiol (1996) 1.58
Cancer incidence among Finnish workers exposed to halogenated hydrocarbons. J Occup Environ Med (1995) 1.56
Characterization of human palladin, a microfilament-associated protein. Mol Biol Cell (2001) 1.56
Effect of organised screening on cervical cancer incidence and mortality in Finland, 1963-1995: recent increase in cervical cancer incidence. Int J Cancer (1999) 1.56
Dietary flavonoids and the risk of lung cancer and other malignant neoplasms. Am J Epidemiol (1997) 1.56
Indications for a novel muscular dystrophy pathway. gamma-filamin, the muscle-specific filamin isoform, interacts with myotilin. J Cell Biol (2000) 1.56
Prospective seroepidemiological study of role of human papillomavirus in non-cervical anogenital cancers. BMJ (1997) 1.55
Magnetic fields of high voltage power lines and risk of cancer in Finnish adults: nationwide cohort study. BMJ (1996) 1.55
Myotilin, a novel sarcomeric protein with two Ig-like domains, is encoded by a candidate gene for limb-girdle muscular dystrophy. Hum Mol Genet (1999) 1.55
Treatment-associated leukemia following testicular cancer. J Natl Cancer Inst (2000) 1.54
Lung cancer after treatment for Hodgkin's disease: focus on radiation effects. Radiat Res (2003) 1.54
Second primary cancer after treatment for cervical cancer. An international cancer registries study. Cancer (1995) 1.52
Debulking or biopsy of malignant glioma in elderly people - a randomised study. Acta Neurochir (Wien) (2003) 1.52
Long-term survival in idiopathic membranous glomerulonephritis: can the course be clinically predicted? Clin Nephrol (1994) 1.51
Selective screening: theory and practice based on high-risk groups of cervical cancer. J Epidemiol Community Health (1979) 1.48
Adhesion molecule expression in symptomatic and asymptomatic carotid stenosis. Neurology (2003) 1.47
Familial cutaneous leiomyomatosis is a two-hit condition associated with renal cell cancer of characteristic histopathology. Am J Pathol (2001) 1.46
Implementation of screening as a public health policy: issues in design and evaluation. J Med Screen (1999) 1.45
The cytotoxic activity of human natural killer cells requires an intact secretory apparatus. Cell Immunol (1981) 1.40
Reduced mortality in dermatitis herpetiformis: a population-based study of 476 patients. Br J Dermatol (2012) 1.40
Stability over time of serum antibody levels to human papillomavirus type 16. J Infect Dis (1998) 1.39
Seemingly complete removal of histologically benign intracranial meningioma: late recurrence rate and factors predicting recurrence in 657 patients. A multivariate analysis. Surg Neurol (1986) 1.39
Incidence and mortality from breast cancer in the Mama Program for Breast Screening in Finland, 1973-1986. Cancer (1994) 1.38
Biosynthesis and intracellular targeting of the CLN3 protein defective in Batten disease. Hum Mol Genet (1998) 1.37
A novel approach to estimate the proportion of hereditary nonpolyposis colorectal cancer of total colorectal cancer burden. Cancer Detect Prev (1994) 1.36
Malignancies and mortality in patients with coeliac disease and dermatitis herpetiformis: 30-year population-based study. Dig Liver Dis (2006) 1.35
Neurofibromatosis 2 tumor suppressor protein colocalizes with ezrin and CD44 and associates with actin-containing cytoskeleton. J Cell Sci (1997) 1.33
Population-based cancer survival in Singapore, 1968 to 1992: an overview. Int J Cancer (2001) 1.33
Dietary antioxidants and the risk of lung cancer. Am J Epidemiol (1991) 1.32
Spatial temporal patterns in childhood leukaemia: further evidence for an infectious origin. EUROCLUS project. Br J Cancer (1998) 1.31
Endothelial ICAM-1 expression associated with inflammatory cell response in human ischemic stroke. Circulation (1996) 1.30
Intracranial hemangiopericytoma: radiology, surgery, radiotherapy, and outcome in 21 patients. Surg Neurol (1985) 1.29
Breast cancer risk among Finnish cabin attendants: a nested case-control study. Occup Environ Med (2005) 1.27
European health systems and cancer care. Ann Oncol (2003) 1.27
Evolution of cerebral tumor necrosis factor-alpha production during human ischemic stroke. Stroke (2001) 1.27
Chronic lymphocytic leukaemia patients have a high risk of Merkel-cell polyomavirus DNA-positive Merkel-cell carcinoma. Br J Cancer (2009) 1.26
Strategies for the introduction of human papillomavirus vaccination: modelling the optimum age- and sex-specific pattern of vaccination in Finland. Br J Cancer (2007) 1.25
Vascular growth factors and receptors in capillary hemangioblastomas and hemangiopericytomas. Am J Pathol (1996) 1.25
Cancer incidence in a kidney-transplanted population. Transpl Int (2000) 1.25
Social class and cancer patient survival in Finland. Am J Epidemiol (1995) 1.24
Three-dimensional integration of brain anatomy and function to facilitate intraoperative navigation around the sensorimotor strip. Hum Brain Mapp (2001) 1.24
Ezrin as a prognostic indicator and its relationship to tumor characteristics in uveal malignant melanoma. Invest Ophthalmol Vis Sci (2001) 1.22